Medications Under Investigation While Ozempic is the most well-known, several other GLP-1 and GIP receptor agonists are included in this litigation: Ozempic (Semaglutide) Wegovy (Semaglutide) Rybelsus (Semaglutide) Mounjaro (Tirzepatide) Zepbound (Tirzepatide) Trulicity (Dulaglutide) Saxenda (Liraglutide) Qualifying Injuries for the Ozempic Lawsuit While many early cases focused on general stomach paralysis, the courts now look for specific diagnoses and documented medical interventions
After that, intersection analysis (Venn plot) was performed between DEHP-related targets and BRCA-related targets, and the intersection targets were considered as the potential targets of DEHP-induced BRCA
doi: 10.2147/CLEP.S391819 59
These tend to occur most often when starting the medication or when the dose is increased, and they typically decrease as the body adjusts
Patients remove fat from areas of the body where there is too much and move the fat to areas of the body where it is too little
Antelmi et al., An impaired autonomic regulation in the post-prandial phase has also been suggested